The Role of Allergies in Bronchial Asthma: Triggers and Treatment

Anema Ander^*
*Correspondence: Anema Ander, Department of Pulmonology, University of Glasgow, Glasgow G12 8QQ, Scotland, UK, Email:

Keywords

Allergies • Bronchial asthma • Chronic respiratory condition

Introduction

When an individual with allergic sensitization comes into contact with their allergen, the immune system releases histamines and other chemicals as a defense mechanism. These chemicals can irritate the airways and cause them to become inflamed and narrowed. The inflammation of the airways, coupled with increased mucus production, makes it difficult for air to flow freely in and out of the lungs. This inflammation and bronchoconstriction are hallmark features of asthma [1]. Inflammation is a complex immune response designed to protect the body from harmful invaders. In the context of allergic asthma, inflammation is initiated when the immune system erroneously identifies harmless substances, known as allergens, as threats. Common allergens include pollen, dust mites, pet dander, mold spores and cockroach allergens.

Pollen from trees, grasses and weeds can trigger asthma symptoms, particularly in individuals with allergic rhinitis (hay fever). These microscopic creatures thrive in bedding, carpets and upholstery. Their fecal matter and body fragments are potent allergens that can exacerbate asthma symptoms [2]. Proteins found in the skin cells, urine and saliva of cats, dogs and other pets can trigger asthma in individuals with pet allergies. Mold grows in damp environments and inhaling mold spores can worsen asthma symptoms, especially in individuals sensitive to molds. Cockroach droppings and body parts can also act as potent asthma triggers, particularly in urban areas with high cockroach infestations.

Literature Review

Identifying and minimizing exposure to allergens is crucial. This may involve using allergen-proof mattress and pillow covers, regularly cleaning and vacuuming and avoiding triggers like smoking or indoor pets. Medications like inhaled corticosteroids, bronchodilators and leukotriene modifiers are commonly prescribed to control asthma symptoms. These medications help reduce inflammation and open the airways. Allergy shots or sublingual tablets are options for individuals with severe allergies that trigger asthma. These treatments gradually desensitize the immune system to allergens, reducing allergic reactions. Maintaining a healthy lifestyle by exercising regularly, managing stress and avoiding respiratory irritants like smoke can help in asthma management [3]. Asthma management should include regular check-ups with a healthcare provider to assess lung function and adjust treatment plans as necessary.

When an individual with allergic sensitization encounters an allergen to which they are sensitized, the immune system's mast cells release chemical mediators, such as histamines and leukotrienes, in response. These chemical mediators trigger an inflammatory cascade in the airways. The airway walls become swollen and immune cells, including eosinophils and lymphocytes, infiltrate the tissue. This inflammation narrows the airways and makes them hyperresponsive to irritants, making it harder for air to pass through. Inflammatory signals also stimulate the goblet cells to produce excess mucus, which further obstructs the airways [4]. The combination of inflammation and mucus production is a hallmark feature of asthma. Inflammation of the airways causes them to become hypersensitive and prone to spasms, a phenomenon known as bronchoconstriction. This narrows the air passages even more, leading to the classic symptoms of asthma, such as wheezing and shortness of breath.

Discussion

Bronchoconstriction is the narrowing of the bronchial tubes, which are responsible for carrying air in and out of the lungs. In the context of allergic asthma, bronchoconstriction occurs as a result of the inflammatory response triggered by allergen exposure. The allergen-induced inflammation causes the smooth muscles surrounding the airways to contract, leading to a narrowing of the air passages. The narrowed airways make it difficult for individuals with allergic asthma to breathe, resulting in symptoms such as wheezing, coughing and shortness of breath. The decreased diameter of the airways restricts the flow of air into and out of the lungs, making it challenging for the individual to inhale and exhale effectively. To compensate for the narrowed airways, individuals with bronchoconstriction must exert more effort to move air in and out of their lungs, which can lead to fatigue and discomfort [5]. Severe bronchoconstriction can lead to asthma attacks, which can be life-threatening if not promptly treated.

Effectively managing allergic asthma involves targeting both inflammation and bronchoconstriction. These anti-inflammatory medications help reduce airway inflammation and prevent asthma symptoms. Short-acting bronchodilators provide rapid relief by relaxing the smooth muscles around the airways, alleviating bronchoconstriction. These medications block the action of leukotriene, inflammatory molecules that contribute to bronchoconstriction and mucus production [6]. Allergy shots or sublingual tablets can help desensitize the immune system to specific allergens, reducing the intensity of the allergic response. Avoiding allergen exposure, maintaining a healthy lifestyle and adhering to an asthma action plan provided by a healthcare provider are essential aspects of managing allergic asthma.

Conclusion

Allergies and bronchial asthma share a complex relationship, with allergies often acting as both triggers and contributors to asthma symptoms. Understanding the role of allergens and their impact on asthma is essential for effective management. Through allergen avoidance, pharmacological interventions, immunotherapy and lifestyle changes, individuals with allergic asthma can achieve better control of their condition and enjoy a higher quality of life. Collaborating closely with healthcare providers is key to developing personalized asthma management plans that address the unique needs of each patient. In conclusion, inflammation and bronchoconstriction are pivotal components of the allergic response in bronchial asthma. Understanding how allergies trigger these processes is crucial for effective asthma management. By addressing both inflammation and bronchoconstriction through a combination of medications, allergen avoidance and lifestyle changes, individuals with allergic asthma can gain better control over their condition and enjoy an improved quality of life. Regular consultation with a healthcare provider is essential for personalized asthma management plans and on-going monitoring.

Acknowledgement

None.

Conflict of Interest

None.

References

1. Hassoun, Dorian, Olivier Malard, Sébastien Barbarot and Antoine Magnan, et al. "Type 2 immunity‐driven diseases: Towards a multidisciplinary approach." Clin Exp Allergy 51 (2021): 1538-1552.

Google Scholar, Crossref, Indexed at

2. Maggi, Enrico, Paola Parronchi, Bruno Giuseppe Azzarone and Lorenzo Moretta. "A pathogenic integrated view explaining the different endotypes of asthma and allergic disorders." Allergy 77 (2022): 3267-3292.

Google Scholar, Crossref, Indexed at

3. McCormick, Justin P and Jivianne T. Lee. "Insights into the implications of coexisting type 2 inflammatory diseases." J Inflamm Res 14 (2021): 4259.

Google Scholar, Crossref, Indexed at

4. Van Bulck, Pauline, Leen Cools, Mysore S. Soumya and Dieudonné T. Nyembue, et al. "A multicenter real‐life study on the multiple reasons for uncontrolled allergic rhinitis." Int Forum Allergy Rhinol 11 (2021): 1452-1460.

Google Scholar, Crossref, Indexed at

5. Wang, Ming, Xiangting Bu, Ge Luan and Liqing Lin, et al. "Distinct type 2-high inflammation associated molecular signatures of chronic rhinosinusitis with nasal polyps with comorbid asthma." Clin Transl Allergy 10 (2020): 1-14.

Google Scholar, Crossref, Indexed at

6. Fiocchi, Alessandro, Maria Cristina Artesani, Carla Riccardi and Maurizio Mennini, et al. "Impact of omalizumab on food allergy in patients treated for asthma: A real-life study." J Allergy Clin Immunol Pract 7 (2019): 1901-1909.

Google Scholar, Crossref, Indexed at